Literature DB >> 6791206

Brain site variations in effects of morphine on electrical self-stimulation.

W T Nelson, S S Steiner, M Brutus, R Farrell, S J Ellman.   

Abstract

Pairs of bipolar electrodes were stereotaxically aimed at two of three sites: the locus coeruleus (LC), the substantia nigra, pars compacta (SNC), and the median forebrain bundle (MFB). Rats were shaped to bar-press for trains of intracranial electrical stimulation presented as pairs of monophasic pulses. The first pulse of a pair (the C, conditioning pulse) was followed by a second pulse (the T, test pulse) after a parametrically varied interval. The effects of chronic morphine administration were tested in a paradigm of 7 days saline, 7 days morphine, 1 day morphine+naloxone, and 6 days post-drug saline. High doses of morphine (5 mg/kg) depressed response rates for intracranial self-stimulation (ICSS). LC placements and those just lateral or ventral to the LC showed large increases in ICSS rates under morphine (2.5 mg/kg). This area was delimited on either side by tips that showed response rate depressions under morphine. MFB placements yielded response rate facilitations under morphine. Sites medial to the MFB and ventral within the MFB showed rate depressions under morphine. Dorsal substantia nigra placements showed facilitated rates, whereas placements ventral within the SNC and substantia nigra, pars reticulata (SNR) produced more variable results, with rates tending to be depressed by morphine. The ICSS procedure may be a useful animal model for detecting the abuse potential of drugs.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791206     DOI: 10.1007/BF00431758

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  Intracranial self-stimulation effects along the route of the nigro-striatal bundle.

Authors:  R A Prado-Alcalá; E W Kent; L D Reid
Journal:  Brain Res       Date:  1975-02-14       Impact factor: 3.252

2.  The effect of morphine on mammalian nerve fibres.

Authors:  I Jurna; W Grossman
Journal:  Eur J Pharmacol       Date:  1977-08-15       Impact factor: 4.432

3.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

4.  Neuronal and neurochemical substrates of reinforcement.

Authors:  R D Hall; F E Bloom; J Olds
Journal:  Neurosci Res Program Bull       Date:  1977-06

5.  Influence of morphine on lateral hypothalamic self-stimulation in the rat.

Authors:  S A Lorens; C L Mitchell
Journal:  Psychopharmacologia       Date:  1973-09-28

6.  Intracranial self-stimulation in rats as a function of various stimulus parameters. I. An empirical study with monopolar electrodes in the medial forebrain bundle.

Authors:  A Wauquier; C J Niemegeers; H A Geivers
Journal:  Psychopharmacologia       Date:  1972

7.  Comparison of the effects of morphine on hypothalamic and medial frontal cortex self-stimulation in the rat.

Authors:  S A Lorens
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

8.  Differential effects of morphine and D-amphetamine on self-stimulation from closely adjacent regions in rat midbrain.

Authors:  J Liebman; D S Segal
Journal:  Brain Res       Date:  1977-11-04       Impact factor: 3.252

9.  Effects of intraventricular 6-hydroxydopamine and replacement therapy with norepinephrine, dopamine, and serotonin on self-stimulation in diencephalic and mesencephalic regions in the rat.

Authors:  M E Olds
Journal:  Brain Res       Date:  1975-11-14       Impact factor: 3.252

10.  Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine.

Authors:  L J Herberg; D N Stephens; K B Franklin
Journal:  Pharmacol Biochem Behav       Date:  1976-05       Impact factor: 3.533

View more
  1 in total

1.  Opioid peptides and self-stimulation of the medial prefrontal cortex in the rat.

Authors:  S G Shaw; F Vives; F Mora
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.